The
group A streptococcus bacterium (
Streptococcus pyogenes, or
GAS) is a form of β-hemolytic
Streptococcus bacteria responsible for
most cases of streptococcal illness. Other types (B, C, D, and G)
may also cause infection. Several virulence factors contribute to
the pathogenesis of GAS, such as
M
protein,
hemolysins, and extracellular
enzymes. For further explanation of these virulence factors, see
the main article on
Streptococcus pyogenes.
Types of infection
Infections are largely categorized by the location of
infection:
(Note that some of these diseases can be caused by other infectious
agents as well.)
Complications
Acute rheumatic fever
Acute rheumatic fever (ARF) is
a complication of respiratory infections caused by GAS. The
M-protein generates antibodies that cross-react with autoantigens
on interstitial connective tissue, particularly of the endocardium
and synovium, that can lead to significant clinical illness.
Although common in developing countries, ARF is rare in the United
States, possibly secondary to improved antibiotic treatment, with
small isolated outbreaks reported only occasionally. It is most
common among children between 5–15 years old and occurs 1–3 weeks
after an untreated GAS pharyngitis . ARF is often clinically
diagnosed based on Jones Criteria, which include:
pancarditis, migratory
polyarthritis of large joints,
subcutaneous nodules,
erythema marginatum, and
sydenham chorea (involuntary, purposeless
movement). The most common clinical finding is a migratory
arthritis involving multiple joints . Other indicators of GAS
infection such as a
DNAase or
ASO serology test must confirm the GAS
infection. Other minor Jones Criteria are fever, elevated
ESR and
arthralgia. Of the most serious complications is
pancarditis, or inflammation of all three heart tissues. A
fibrinous
pericarditis can develop with
a classic friction rub that can be auscultated. This will give
increasing pain upon reclining. Further endocarditis can develop
with aseptic vegetations along the valve closure lines,
particularly the mitral valve. Chronic rheumatic heart disease
mostly affects the
mitral valve which
can become thickened with calcification of the leaflets, often
causing fusion of the commissures and
chordae tendineae. Other findings of ARF
include
erythema marginatum
(usually over the spine or other bony areas) and a red expanding
rash on the trunk and extremities that recurs over weeks to months.
Because of the different ways ARF presents itself, the disease may
be difficult to diagnose. A neurological disorder, Sydenham
chorea, can occur months after an
initial attack, causing jerky involuntary movements, muscle
weakness, slurred speech, and personality changes. Initial episodes
of ARF as well as recurrences can be prevented by treatment with
appropriate antibiotics. It is important to distinguish ARF from
rheumatic heart disease. ARF
is an acute inflammatory reaction with pathognomonic Aschoff bodies
histologically and RHD is a non-inflammatory sequelae of ARF.
Post-streptococcal glomerulonephritis
Post-streptococcal
glomerulonephritis (PSGN) is an uncommon complication of either
a strep throat or a streptococcal skin infection. Symptoms of PSGN
develop within 10 days following a strep throat or 3 weeks
following a GAS skin infection. PSGN involves inflammation of the
kidney. Symptoms include pale skin, lethargy, loss of appetite,
headache and dull back pain. Clinical findings may include
dark-colored urine, swelling of different parts of the body
(edema), and high blood pressure. Treatment of PSGN consists of
supportive care.
Severe streptococcal infections
Some strains of group A streptococci (GAS) cause severe infection.
Those at greatest risk include children with
chickenpox; persons with
suppressed immune systems;
burn victims; elderly persons with
cellulitis,
diabetes,
blood
vessel disease, or
cancer; and persons
taking
steroid treatments or
chemotherapy.
Intravenous drug users also are at high
risk. GAS is an important cause of
puerperal fever world-wide, causing serious
infection and, if not promptly diagnosed and treated, death in
newly delivered mothers. Severe GAS disease may also occur in
healthy persons with no known risk factors.
All severe GAS infections may lead to
shock,
multisystem organ failure, and
death. Early recognition and treatment are
critical. Diagnostic tests include
blood
counts and
urinalysis as well as
cultures of blood or fluid from a wound site. The antibiotic of
choice is
penicillin, to which GAS is
particularly susceptible and has never been found to be resistant.
Erythromycin and
clindamycin are other treatment options, though
resistance to these antibiotics exists.
Severe Group A streptococcal infections often occur sporadically
but can be spread by person-to-person contact.
Close contacts of people affected by severe Group A streptococcal infections, defined as those who have had prolonged household contact in the week before the onset of illness, may be at increased risk of infection. This increased risk may be due to a combination of shared genetic susceptibility within the family, close contact with carriers, and the virulence of the Group A streptococcal strain that is involved.
Public Health policies internationally
reflect differing views of how the close contacts of people
affected by severe Group A streptococcal infections should be
treated.
Health Canada and the US CDC
recommend close contacts see their doctor for full evaluation and
may require antibiotics; current UK
Health Protection Agency guidance
is that, for a number of reasons, close contacts should not receive
antibiotics unless they are symptomatic but that they should
receive information and advice to seek immediate medical attention
if they develop symptoms.
Relation with tics and OCD
In recent years, children with
tic
disorders and
obsessive compulsive disorder
(OCD) hypothesized to be caused by an autoimmune response to group
A beta-hemolytic streptococcal infection (
PANDAS) have been identified.
References
- Gamba MA, Martinelli M, Schaad HJ, Streuli RA, DiPersio J,
Matter L, et al. Familial transmission of a serious disease
producing group A streptococcus clone:case reports and review. Clin
Infect Dis 1997; 24: 1118-21.
- Health Protection Agency, Group A Streptococcus Working Group
(2004). Interim UK guidelines for management of close community
contacts of invasive group A streptococcal disease. Commun Dis
Public Health 2004; 7(4): 354-61. Available at:
http://www.hpa.org.uk/cdph/issues/CDPHVol7/no4/guidelines1_4_04.pdf
- Guidelines for management of contacts of cases of invasive
group A streptococcal disease (GAS) including streptococcal toxic
shock syndrome (STSS) and necrotising fasciitis. Toronto, Ontario:
Ministry of Health; 1995. Available at:
http://www.microbiology.mtsinai.on.ca/protocols/pdf/k5b.pdf
- [1]
- History of Treatment of OCD. Stanford School of
Medicine. Retrieved on 2007-04-12[2]
Note:
Elements of the original text of this article are taken from the
NIH
Fact Sheet "Group A Streptococcal Infections",
dated March 1999. As a work of the U.S. Federal Government
without any other copyright notice, this is assumed to be a
public domain resource.
External links